Clinical Trial Update: Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the efficacy and safety of olaparib in pretreated colorectal cancer patients, analyzed by MSI status; results posted following study com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Olaparib (Olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-11-09